Product
Somatostatin
3 clinical trials
3 indications
Indication
ObesityIndication
Hepatocellular CarcinomaIndication
HypoglycemiaClinical trial
Stimulation of Regional Lipolysis and Adipocyte Lipolysis ProteinsStatus: Not yet recruiting, Estimated PCD: 2027-04-01
Clinical trial
Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma: Multicenter Randomized Double-blind Placebo Controlled Trial (SOMAPROTECT01)Status: Completed, Estimated PCD: 2024-04-30
Clinical trial
Effect of Liver Glycogen Content on Hypoglycemic CounterregulationStatus: Active (not recruiting), Estimated PCD: 2025-05-31